Bayer Appeals India Patent Ruling on Drug License

Germany’s Bayer AG has appealed against the grant of a compulsory license by India’s patent authority to a local generic drug producer for its kidney- and liver-cancer medicine, Nexavar (sorafenib).
The Wall Street Journal